Intravenous Thrombolysis With rhTNK-tPA for Acute Non-large Vessel Occlusion in Extended Time Window

NCT05752916 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

570

Enrollment

OTHER

Sponsor class

Conditions

Acute Ischemic Stroke

Interventions

DRUG: rhTNK-tPA
DRUG: Antiplatelet Agents

Sponsor

Xuanwu Hospital, Beijing

Collaborators

[object Object]
[object Object]